DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,461,265 | -11.8% | 274,926 | -3.8% | 0.16% | -11.7% |
| Q2 2023 | $68,574,303 | +3.2% | 285,752 | +8.4% | 0.18% | -8.6% |
| Q1 2023 | $66,454,039 | -35.4% | 263,663 | -31.9% | 0.20% | -25.9% |
| Q4 2022 | $102,861,891 | +58.9% | 387,375 | +54.5% | 0.27% | +29.1% |
| Q3 2022 | $64,742,000 | -4.6% | 250,743 | -6.3% | 0.21% | +27.2% |
| Q2 2022 | $67,867,000 | -28.3% | 267,483 | -17.2% | 0.16% | +0.6% |
| Q1 2022 | $94,708,000 | -33.4% | 322,868 | -25.3% | 0.16% | -19.1% |
| Q4 2021 | $142,174,000 | +138.3% | 432,238 | +120.4% | 0.20% | +89.5% |
| Q3 2021 | $59,659,000 | -39.5% | 196,082 | -46.7% | 0.10% | -42.3% |
| Q2 2021 | $98,683,000 | +144.9% | 367,738 | +105.4% | 0.18% | +130.4% |
| Q1 2021 | $40,291,000 | -58.8% | 179,007 | -59.3% | 0.08% | -62.0% |
| Q4 2020 | $97,784,000 | +246.1% | 440,154 | +235.4% | 0.21% | +170.1% |
| Q3 2020 | $28,254,000 | +25.8% | 131,215 | +3.3% | 0.08% | 0.0% |
| Q2 2020 | $22,463,000 | +84.3% | 127,041 | +44.2% | 0.08% | +83.3% |
| Q1 2020 | $12,185,000 | +21.7% | 88,078 | +35.0% | 0.04% | +75.0% |
| Q4 2019 | $10,014,000 | -90.7% | 65,248 | -91.3% | 0.02% | -92.5% |
| Q3 2019 | $108,216,000 | +151.7% | 749,267 | +142.8% | 0.32% | +78.3% |
| Q2 2019 | $43,000,000 | -1.4% | 308,657 | -6.5% | 0.18% | +4.0% |
| Q1 2019 | $43,592,000 | -40.8% | 330,185 | -53.8% | 0.17% | -49.9% |
| Q4 2018 | $73,693,000 | +150.9% | 714,700 | +164.3% | 0.34% | +163.4% |
| Q3 2018 | $29,375,000 | +87.6% | 270,383 | +70.5% | 0.13% | +52.3% |
| Q2 2018 | $15,660,000 | -64.2% | 158,627 | -64.5% | 0.09% | -61.9% |
| Q1 2018 | $43,742,000 | +3.7% | 447,231 | -1.6% | 0.23% | +17.7% |
| Q4 2017 | $42,174,000 | +6.5% | 454,415 | -1.6% | 0.19% | -16.9% |
| Q3 2017 | $39,616,000 | +2.5% | 461,829 | +0.8% | 0.23% | +13.8% |
| Q2 2017 | $38,660,000 | +29.0% | 458,144 | +30.8% | 0.20% | +58.6% |
| Q1 2017 | $29,969,000 | +72.4% | 350,381 | +56.9% | 0.13% | +43.8% |
| Q4 2016 | $17,387,000 | +234.8% | 223,343 | +237.1% | 0.09% | +206.9% |
| Q3 2016 | $5,193,000 | -81.2% | 66,251 | -75.8% | 0.03% | -82.2% |
| Q2 2016 | $27,686,000 | +36.8% | 274,236 | +28.5% | 0.16% | +30.4% |
| Q1 2016 | $20,245,000 | +8.2% | 213,476 | +6.0% | 0.12% | +30.2% |
| Q4 2015 | $18,707,000 | +10.6% | 201,328 | +1.4% | 0.10% | +4.3% |
| Q3 2015 | $16,920,000 | +28.0% | 198,468 | +28.6% | 0.09% | +39.4% |
| Q2 2015 | $13,217,000 | +209.8% | 154,362 | +207.3% | 0.07% | +247.4% |
| Q1 2015 | $4,266,000 | -0.7% | 50,231 | +0.3% | 0.02% | +18.8% |
| Q4 2014 | $4,294,000 | -14.3% | 50,104 | -24.1% | 0.02% | -20.0% |
| Q3 2014 | $5,012,000 | +17.5% | 66,000 | +21.8% | 0.02% | +17.6% |
| Q2 2014 | $4,267,000 | +6.0% | 54,165 | +0.9% | 0.02% | 0.0% |
| Q1 2014 | $4,027,000 | +67.9% | 53,672 | +73.0% | 0.02% | +70.0% |
| Q4 2013 | $2,399,000 | +324.6% | 31,029 | +280.7% | 0.01% | +233.3% |
| Q3 2013 | $565,000 | +5.4% | 8,150 | -4.0% | 0.00% | 0.0% |
| Q2 2013 | $536,000 | +3.3% | 8,488 | +1.1% | 0.00% | +50.0% |
| Q1 2013 | $519,000 | – | 8,395 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |